257
Views
1
CrossRef citations to date
0
Altmetric
Review

Management of breast cancer diagnosed during pregnancy: global perspectives

, , &
Pages 1301-1308 | Received 14 Mar 2022, Accepted 17 Nov 2022, Published online: 08 Dec 2022

References

  • Bajpai J, Shylasree T. Pregnancy-associated breast cancer: controversies and consensus! Oncobiology and Targets. 2016;3(1):6.
  • Iqbal J, Amir E, Rochon PA, et al. Association of the timing of pregnancy with survival in women with breast cancer. JAMA Oncol. 2017; 3(5): 659–665.
  • Bajpai J, Simha V, Shylasree TS, et al. Pregnancy associated breast cancer (PABC): report from a gestational cancer registry from a tertiary cancer care centre. India.TheBreast. 2021;56(88–95):0960–9776.
  • Langer A, Mohallem M, Berment H, et al. Breast lumps in pregnant women. Diagn Interv Imaging. 2015;96(10):1077–1087.
  • Amant F, Lefrère H, Borgeset VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used .thelancet.com/oncology. 2021 Jun 22
  • Callihan E, Gao D, Jindal S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy associated breast cancer. Breast Cancer Res Treat. 2013;138(2):549–559.
  • Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887–896.
  • Lyons T, Schedin P, Borges V, et al. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia. 2009;14(2):87–98.
  • Amant F, Von Minckwitz G, Han S, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013;31(20):2532–2539.
  • Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1(8):1145–1153.
  • Silverstein J, Post AL, Chien AJ, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020; 16: 545–557.
  • Paris I, Di Giorgio D, Carbognin L, et al. Pregnancy-associated breast cancer: a multidisciplinary approach. clin. Breast Cancer. 2020. 10.1016/j.clbc.2020.07.007.
  • Mittra I, Mishra GA, Dikshit RP, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;372. 10.1136/bmj.n256.
  • Stovall M, Blackwell CR, Cundiff J, et al. Fetal dose from radiotherapy with photon beams: report of AAPM radiation therapy committee task group No. 36. Med Phys. 1995;22(1):63–82.
  • Ray J, Vermeulen MJ, Bharatha A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016 Sep 6;316(9):952–961.
  • Nissan N, Furman-Haran E, Allweis T, et al. Noncontrast breast MRI during pregnancy using diffusion tensor imaging: a feasibility study. Journal of Magnetic Resonance Imaging: JMRI. 2019 Feb;49(2):508–517.
  • Nissan N, Bauer E, Moss Massasa EE, et al. Breast MRI during pregnancy and lactation: clinical challenges and technical advances. Insights Imaging. 2022 Apr 9 13(1):71.
  • Nissan N, Allweis T, Menes T, et al. Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps. EurRadiol. 2020 Feb;30(2):767–777.
  • Nissan N, Sandler I, Eifer M, et al. Physiologic and hypermetabolic breast 18-F FDG uptake on PET/CT during lactation. EurRadiol. 2021 Jan;31(1):163–170.
  • Vashi R, Hooley R, Butler R, et al. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy- associated breast cancer. AJR: 200, February 2013.
  • Couch FJ, Hart SN, Sharma P, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol. 2015;33(4):3034–3311.
  • C GJ, Chun J, Kaplowitz E, et al. Pregnancy‐associated breast cancer in a contemporary cohort of newly diagnosed women. Breast J. 2019;26(4):668–671. 1–4.
  • Toesca A, Gentillini O, Peccatori F, et al. Locoregional treatment of breast cancer during pregnancy. Gynecol Surg. 2014;11(4):279–284.
  • Caragacianu DL, Mayer EL, Chun YS, et al. Immediate breast reconstruction following mastectomy in pregnant women with breast cancer. J Surg Oncol. 2016; 114: 140–143.
  • Gropper AB, Calvillo KZ, Dominici L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann SurgOncol. 2014; 21: 2506–2511.
  • Han SN, Amamnt F, Sangalli C, et al. Sentinel lymph node biopsy for breast cancer treatment during pregnancy-on behalf of the international network of cancer, infertility and pregnancy (INCIP) and the German Breast Group (GBG)[abstract]. Ann Oncol. 2014;25(4):266.
  • Morocco DE. Pregnancy-Associated Breast Cancer. U.S. Pharm. 2015.https://www.uspharmacist.com/article/pregnancy-associated-breast-cancer (accessed 2020 Dec 10).
  • National Toxicology Program. NTP monograph: developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy. NTP Monogr. 20132; (2): i–214.
  • Van Calsteren K. Chemotherapy during pregnancy: pharmacokinetics and impact on fetal neurological development. Facts Views Vis ObGyn. (accessed 2021 Jan 13 2010;2:278–286. http://www.ncbi.nlm.nih.gov/pubmed/25009715
  • Macdonald HR. Pregnancy associated breast cancer. Breast J. 2020;26(1):81–85.
  • Lambertini M, Kroman N, Ameye L, et al. Long-term safety of pregnancy following breast cancer according to estrogen receptor status | JNCI: journal of the National Cancer Institute | oxford Academic. J Natl Cancer Inst. 2018 [(accessed 2020 Jul 3];110(4):426–429. https://academic.oup.com/jnci/article/110/4/426/4565505
  • Tutt A, Ellis P, Kilburn L. The TNT trial: a randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012). Paper presented at: San Antonio Breast Cancer Symposium 2014; 2014 Dec 9-13; San Antonio, TX. S3–01.
  • von Minckwitz G, Schneeweiss A, Loibl S, et al. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial. Lancet Oncol. 2014;15(7):747–756.
  • Sikov WM, Berry DA, Perou CM, et al. Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance). J Clin Oncol. 2015;33(1):13–21.
  • Cardonick E, Gilmandyar D, Somer RA, et al. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol. 2012;120(6):1267–1272.
  • Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349–357.
  • Oosting S, Van der Veldt AAM, GeurtsvanKessel CH, et al. LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors. Ann Oncol. 2021;32:S1337.
  • Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–2282.
  • Azim HA, Metzger-Filho O, De Azambuja E, et al. Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial. BIG 01-01. Breast Cancer Res Treat; 2012, Vol. 133: 387–391. DOI: 10.1007/s10549-012-1996-6
  • Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015 Nov 5;37319:1824–1834. Epub 2015 Sep 28.
  • Borges V, Elder A, Lyons T, et al. Deciphering pro-lymphangiogenic programs during mammary involution and postpartum breast cancer. Front Oncol. 2016;6:227.
  • Shao C, Yu Z, Xiao J, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis. BMC Cancer. 2020;10(1):746.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.